$3.27 Billion is the total value of Nantahala Capital Management's 130 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 39.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $674,055,000 | +14.8% | 4,500,000 | +9.8% | 20.62% | +16.5% |
| W | WAYFAIR INCcall | $379,477,000 | +47.3% | 1,304,000 | 0.0% | 11.61% | +49.4% | |
| CVNA | Sell | CARVANA COcall | $230,823,000 | +6.5% | 1,034,800 | -42.6% | 7.06% | +8.1% |
| SGMS | SCIENTIFIC GAMES CORPcall | $151,112,000 | +125.8% | 4,328,600 | 0.0% | 4.62% | +129.0% | |
| IWM | Sell | ISHARES TRcall | $104,853,000 | -39.0% | 700,000 | -41.7% | 3.21% | -38.1% |
| CDXS | CODEXIS INC | $62,967,000 | +3.0% | 5,363,484 | 0.0% | 1.93% | +4.4% | |
| DLB | Buy | DOLBY LABORATORIES INC | $62,214,000 | +1.5% | 938,656 | +0.9% | 1.90% | +3.0% |
| THC | TENET HEALTHCARE CORPcall | $58,886,000 | +35.3% | 2,402,500 | 0.0% | 1.80% | +37.3% | |
| QURE | Buy | UNIQURE NV | $58,315,000 | -17.5% | 1,583,358 | +1.0% | 1.78% | -16.3% |
| VG | Buy | VONAGE HLDGS CORP | $53,029,000 | +2.7% | 5,183,712 | +1.0% | 1.62% | +4.2% |
| QADA | Buy | QAD INCcl a | $49,980,000 | +3.1% | 1,184,365 | +0.9% | 1.53% | +4.7% |
| VAC | Sell | MARRIOTT VACTINS WORLDWID CO | $47,919,000 | +7.6% | 527,683 | -2.6% | 1.47% | +9.2% |
| Buy | APTOSE BIOSCIENCES INC | $41,335,000 | +9.6% | 6,889,157 | +15.3% | 1.26% | +11.2% | |
| WYND | Buy | WYNDHAM DESTINATIONS INC | $40,124,000 | +43.3% | 1,304,435 | +31.2% | 1.23% | +45.2% |
| CAR | AVIS BUDGET GROUPput | $39,480,000 | +15.0% | 1,500,000 | 0.0% | 1.21% | +16.7% | |
| QURE | UNIQURE NVcall | $39,132,000 | -18.3% | 1,062,500 | 0.0% | 1.20% | -17.1% | |
| TFFP | Buy | TFF PHARMACEUTICALS INC | $37,549,000 | +661.0% | 2,032,988 | +137.4% | 1.15% | +670.5% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $35,563,000 | -0.2% | 1,919,190 | +0.6% | 1.09% | +1.2% |
| CUE | Buy | CUE BIOPHARMA INC | $35,250,000 | -38.2% | 2,342,216 | +0.7% | 1.08% | -37.3% |
| BMYRT | New | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $34,734,000 | – | 15,437,336 | +100.0% | 1.06% | – |
| CASH | META FINL GROUP INC | $34,591,000 | +5.8% | 1,799,727 | 0.0% | 1.06% | +7.3% | |
| IMXI | Sell | INTERNATIONAL MNY EXPRESS IN | $33,308,000 | -8.2% | 2,318,668 | -20.4% | 1.02% | -6.9% |
| FBIO | Buy | FORTRESS BIOTECH INC | $33,229,000 | +180.2% | 8,224,938 | +85.9% | 1.02% | +183.8% |
| GDEN | GOLDEN ENTMT INC | $29,427,000 | +55.0% | 2,127,788 | 0.0% | 0.90% | +57.3% | |
| LXFR | Buy | LUXFER HOLDINGS PLC | $28,585,000 | -10.4% | 2,277,665 | +1.1% | 0.87% | -9.1% |
| IMTX | New | IMMATICS N.V | $26,968,000 | – | 2,622,164 | +100.0% | 0.82% | – |
| TA | Buy | TRAVELCENTERS OF AMERICA INC | $25,377,000 | +388.4% | 1,298,740 | +284.9% | 0.78% | +394.3% |
| FCFS | New | FIRSTCASH INC | $24,690,000 | – | 431,569 | +100.0% | 0.76% | – |
| DXPE | Sell | DXP ENTERPRISES INC | $24,204,000 | -24.0% | 1,500,559 | -6.2% | 0.74% | -22.9% |
| TBBK | BANCORP INC DEL | $22,671,000 | -11.8% | 2,623,939 | 0.0% | 0.69% | -10.6% | |
| WRLD | Sell | WORLD ACCEP CORP DEL | $22,381,000 | -7.8% | 212,042 | -42.8% | 0.68% | -6.4% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $22,145,000 | -25.3% | 3,123,430 | -2.5% | 0.68% | -24.3% |
| PENN | PENN NATL GAMING INCput | $21,810,000 | +138.0% | 300,000 | 0.0% | 0.67% | +141.7% | |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $20,193,000 | +11.0% | 2,378,426 | +36.1% | 0.62% | +12.6% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $19,759,000 | – | 1,338,691 | +100.0% | 0.60% | – |
| THC | Sell | TENET HEALTHCARE CORP | $19,172,000 | -52.8% | 782,225 | -65.2% | 0.59% | -52.2% |
| ALTG | Buy | ALTA EQUIPMENT GROUP INC | $19,148,000 | +1.2% | 2,445,524 | +0.4% | 0.59% | +2.6% |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $18,896,000 | -13.4% | 5,065,955 | +1.2% | 0.58% | -12.2% |
| HCA | HCA HEALTHCARE INCput | $18,702,000 | +28.5% | 150,000 | 0.0% | 0.57% | +30.3% | |
| SLNO | SOLENO THERAPEUTICS INC | $18,640,000 | +13.1% | 7,426,368 | 0.0% | 0.57% | +14.7% | |
| New | AKUMIN INC | $18,472,000 | – | 5,683,712 | +100.0% | 0.56% | – | |
| UPLD | Sell | UPLAND SOFTWARE INC | $18,040,000 | -0.9% | 478,523 | -8.7% | 0.55% | +0.5% |
| CAR | AVIS BUDGET GROUPcall | $17,311,000 | +15.0% | 657,700 | 0.0% | 0.53% | +16.5% | |
| INAQU | New | INSU ACQUISITION CORP IIunit 09/04/2025 | $16,312,000 | – | 1,575,000 | +100.0% | 0.50% | – |
| EHTH | Buy | EHEALTH INC | $15,405,000 | +408.2% | 195,000 | +532.1% | 0.47% | +417.6% |
| EXAS | EXACT SCIENCES CORPput | $15,293,000 | +17.3% | 150,000 | 0.0% | 0.47% | +19.1% | |
| FRG | Sell | FRANCHISE GROUP INC | $15,174,000 | -40.1% | 598,334 | -48.3% | 0.46% | -39.3% |
| JYNT | JOINT CORP | $14,762,000 | +13.9% | 848,881 | 0.0% | 0.45% | +15.6% | |
| CRHM | CRH MED CORP | $14,668,000 | +3.5% | 6,777,905 | 0.0% | 0.45% | +5.2% | |
| INSU | New | INSURANCE ACQUISITION CORPcl a | $14,474,000 | – | 1,225,538 | +100.0% | 0.44% | – |
| PAR | Sell | PAR TECHNOLOGY CORP | $14,447,000 | -13.4% | 356,637 | -36.0% | 0.44% | -12.1% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $14,424,000 | -82.6% | 5,746,623 | -5.8% | 0.44% | -82.3% |
| SIC | Buy | SELECT INTERIOR CONCEPTS INCcl a | $14,195,000 | +98.9% | 2,057,208 | +0.9% | 0.43% | +101.9% |
| FTIVU | New | FINTECH ACQUISITION CORP IVunit 12/31/2025 | $13,698,000 | – | 1,950,000 | +100.0% | 0.42% | – |
| SCPL | Sell | SCIPLAY CORPcl a | $13,256,000 | -34.5% | 817,282 | -40.1% | 0.40% | -33.6% |
| CERC | Buy | CERECOR INC | $13,177,000 | -10.8% | 5,791,950 | +1.9% | 0.40% | -9.4% |
| HAL | HALLIBURTON COcall | $13,089,000 | -7.2% | 1,086,200 | 0.0% | 0.40% | -5.9% | |
| VMD | VIEMED HEALTHCARE INC | $12,991,000 | -9.7% | 1,498,100 | 0.0% | 0.40% | -8.5% | |
| IWM | Sell | ISHARES TRrussell 2000 etf | $12,944,000 | -61.5% | 86,413 | -63.2% | 0.40% | -60.9% |
| EVRI | Buy | EVERI HLDGS INC | $12,714,000 | +145.7% | 1,541,052 | +53.7% | 0.39% | +149.4% |
| ZVO | Buy | ZOVIO INC | $11,412,000 | +40.6% | 2,853,087 | +7.5% | 0.35% | +42.4% |
| DHX | DHI GROUP INC | $10,937,000 | +7.6% | 4,839,595 | 0.0% | 0.34% | +9.5% | |
| FTACU | FINTECH ACQUISITION CORP IIIunit 12/01/2023 | $10,728,000 | -12.6% | 977,022 | 0.0% | 0.33% | -11.4% | |
| KROS | Buy | KEROS THERAPEUTICS INC | $10,677,000 | +3.5% | 276,827 | +0.7% | 0.33% | +5.1% |
| LINC | Sell | LINCOLN EDL SVCS CORP | $10,268,000 | +8.0% | 1,860,192 | -23.7% | 0.31% | +9.4% |
| SGMS | Sell | SCIENTIFIC GAMES CORP | $10,047,000 | +8.9% | 287,802 | -51.8% | 0.31% | +10.4% |
| FTOCU | New | FTAC OLYMPUS ACQUISITION CORunit 08/24/2025 | $10,000,000 | – | 1,000,000 | +100.0% | 0.31% | – |
| Buy | DARIOHEALTH CORP | $9,971,000 | +633.7% | 594,222 | +177.6% | 0.30% | +643.9% | |
| ARYBU | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $9,350,000 | -5.1% | 850,000 | 0.0% | 0.29% | -3.7% | |
| Buy | FALCON MINERALS CORP | $8,072,000 | +26.4% | 3,308,154 | +65.8% | 0.25% | +28.0% | |
| CBIO | CATALYST BIOSCIENCES INC | $7,834,000 | -26.7% | 1,821,749 | 0.0% | 0.24% | -25.5% | |
| ARYA | New | ARYA SCIENCES ACQUISITION CO | $7,571,000 | – | 700,000 | +100.0% | 0.23% | – |
| AMRS | Buy | AMYRIS INC | $7,391,000 | -41.3% | 2,531,191 | +52.1% | 0.23% | -40.4% |
| GLMD | GALMED PHARMACEUTICALS LTD | $7,317,000 | -26.2% | 2,072,745 | 0.0% | 0.22% | -25.1% | |
| RFL | Sell | RAFAEL HLDGS INC | $7,031,000 | +4.0% | 453,635 | -3.6% | 0.22% | +5.4% |
| NATR | NATURES SUNSHINE PRODS INC | $6,911,000 | +28.4% | 597,310 | 0.0% | 0.21% | +30.2% | |
| SIGA | Sell | SIGA TECHNOLOGIES INC | $6,701,000 | -3.5% | 975,438 | -17.0% | 0.20% | -1.9% |
| HCA | Sell | HCA HEALTHCARE INC | $6,415,000 | -77.7% | 51,448 | -82.7% | 0.20% | -77.4% |
| SSKN | STRATA SKIN SCIENCES INC | $6,325,000 | +17.4% | 4,685,062 | 0.0% | 0.19% | +19.1% | |
| RDI | Buy | READING INTERNATIONAL INCcl a | $6,121,000 | -8.0% | 1,900,818 | +21.5% | 0.19% | -7.0% |
| XELA | Sell | EXELA TECHNOLOGIES INC | $5,842,000 | -33.2% | 15,184,747 | -3.8% | 0.18% | -32.2% |
| AFI | ARMSTRONG FLOORING INC | $5,370,000 | +15.4% | 1,556,435 | 0.0% | 0.16% | +17.1% | |
| RCII | Buy | RENT A CTR INC NEW | $5,295,000 | +8.4% | 177,165 | +0.9% | 0.16% | +10.2% |
| VG | New | VONAGE HLDGS CORPcall | $5,115,000 | – | 500,000 | +100.0% | 0.16% | – |
| ACET | New | ADICET BIO INC | $4,937,000 | – | 415,189 | +100.0% | 0.15% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $4,477,000 | – | 174,461 | +100.0% | 0.14% | – |
| STRM | STREAMLINE HEALTH SOLUTIONS | $4,296,000 | +17.3% | 2,753,599 | 0.0% | 0.13% | +19.1% | |
| YTRA | YATRA ONLINE INC | $3,990,000 | +10.4% | 5,320,000 | 0.0% | 0.12% | +11.9% | |
| SRL | SCULLY ROYALTY LTD | $3,702,000 | -35.4% | 753,885 | 0.0% | 0.11% | -34.7% | |
| APEN | Buy | APOLLO ENDOSURGERY INC | $3,235,000 | +7.0% | 1,913,972 | +3.5% | 0.10% | +8.8% |
| DMAC | Buy | DIAMEDICA THERAPEUTICS INC | $3,206,000 | -38.3% | 756,193 | +0.8% | 0.10% | -37.6% |
| GRAY | New | GRAYBUG VISION INC | $3,178,000 | – | 250,000 | +100.0% | 0.10% | – |
| MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $3,008,000 | +20.8% | 751,943 | +0.6% | 0.09% | +22.7% |
| ACER | ACER THERAPEUTICS INC | $2,853,000 | -16.0% | 990,655 | 0.0% | 0.09% | -14.7% | |
| DVD | Buy | DOVER MOTORSPORTS INC | $2,673,000 | +1.7% | 1,895,541 | +11.8% | 0.08% | +3.8% |
| NEOS | NEOS THERAPEUTICS INC | $2,445,000 | -22.6% | 4,610,000 | 0.0% | 0.08% | -21.1% | |
| BCTG | New | BCTG ACQUISITION CORP | $2,072,000 | – | 200,000 | +100.0% | 0.06% | – |
| PRTY | New | PARTY CITY HOLDCO INC | $2,026,000 | – | 834,002 | +100.0% | 0.06% | – |
| ONCT | New | ONCTERNAL THERAPEUTICS INC | $2,041,000 | – | 1,200,747 | +100.0% | 0.06% | – |
| CYRN | Buy | CYREN LTD | $1,986,000 | +58.4% | 1,839,263 | +73.1% | 0.06% | +60.5% |
| HTGM | Buy | HTG MOLECULAR DIAGNOSTICS IN | $1,690,000 | -53.6% | 5,113,958 | +1.1% | 0.05% | -52.7% |
| TSHA | New | TAYSHA GENE THERAPIES INC | $1,680,000 | – | 75,000 | +100.0% | 0.05% | – |
| HTZGQ | HERTZ GLOBAL HLDGS INCcall | $1,443,000 | -21.3% | 1,300,000 | 0.0% | 0.04% | -20.0% | |
| ONDK | Sell | ON DECK CAP INC | $1,410,000 | -58.1% | 881,197 | -81.2% | 0.04% | -57.8% |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $865,000 | – | 691,651 | +100.0% | 0.03% | – |
| ENVA | New | ENOVA INTL INC | $793,000 | – | 48,363 | +100.0% | 0.02% | – |
| INSUW | New | INSURANCE ACQUISITION CORP*w exp 03/31/202 | $692,000 | – | 249,999 | +100.0% | 0.02% | – |
| NNBR | Sell | NN INC | $685,000 | -65.3% | 132,821 | -68.1% | 0.02% | -64.4% |
| MOTS | MOTUS GI HLDGS INC | $408,000 | -26.0% | 417,708 | 0.0% | 0.01% | -29.4% | |
| NK | Buy | NANTKWEST INC | $351,000 | -42.8% | 50,613 | +1.2% | 0.01% | -42.1% |
| ALTGWS | ALTA EQUIPMENT GROUP INC*w exp 02/14/202 | $322,000 | -44.5% | 187,500 | 0.0% | 0.01% | -41.2% | |
| MDIA | MEDIACO HLDG INCcl a | $260,000 | -49.5% | 98,894 | 0.0% | 0.01% | -50.0% | |
| FTAC | New | FINTECH ACQUISITION CORP III | $237,000 | – | 22,978 | +100.0% | 0.01% | – |
| FALCON MINERALS CORP*w exp 07/21/202 | $201,000 | -28.7% | 878,022 | 0.0% | 0.01% | -33.3% | ||
| W | Exit | WAYFAIR INCcl a | $0 | – | -164 | -100.0% | -0.00% | – |
| CVNA | Exit | CARVANA COcl a | $0 | – | -583 | -100.0% | -0.00% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -4,859 | -100.0% | -0.01% | – |
| CEMI | Exit | CHEMBIO DIAGNOSTICS INC | $0 | – | -250,793 | -100.0% | -0.02% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INCput | $0 | – | -50,000 | -100.0% | -0.03% | – |
| EBIX | Exit | EBIX INC | $0 | – | -66,997 | -100.0% | -0.04% | – |
| NNI | Exit | NELNET INCcl a | $0 | – | -34,900 | -100.0% | -0.05% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -9,566,844 | -100.0% | -0.08% | – |
| GEENQ | Exit | GLOBAL EAGLE ENTMT INC | $0 | – | -1,161,255 | -100.0% | -0.17% | – |
| TORC | Exit | RESTORBIO INC | $0 | – | -2,906,340 | -100.0% | -0.19% | – |
| INSUU | Exit | INSURANCE ACQUISITION CORPunit 03/31/2024 | $0 | – | -500,000 | -100.0% | -0.23% | – |
| ARYAU | Exit | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $0 | – | -452,944 | -100.0% | -0.25% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -533,788 | -100.0% | -0.27% | – |
| CATS | Exit | CATASYS INC | $0 | – | -417,249 | -100.0% | -0.31% | – |
| CZR | Exit | CAESARS ENTMT CORPcall | $0 | – | -331,000 | -100.0% | -0.40% | – |
| INMD | Exit | INMODE LTD | $0 | – | -511,856 | -100.0% | -0.44% | – |
| PTON | Exit | PELOTON INTERACTIVE INC | $0 | – | -300,000 | -100.0% | -0.52% | – |
| ARYA | Exit | ARYA SCIENCES ACQUISITION CO | $0 | – | -1,112,087 | -100.0% | -0.53% | – |
| MED | Exit | MEDIFAST INC | $0 | – | -272,957 | -100.0% | -1.14% | – |
| KRE | Exit | SPDR SER TRput | $0 | – | -1,000,000 | -100.0% | -1.16% | – |
| RH | Exit | RH | $0 | – | -157,920 | -100.0% | -1.18% | – |
| HYG | Exit | ISHARES TRput | $0 | – | -1,200,000 | -100.0% | -2.95% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -400,000 | -100.0% | -3.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.